Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-licensure Safety Study of IMOJEV in Thailand
NCT01981967Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2013
- Primary completion
- Apr 2015
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of japanese encephalitis chimeric virus vaccine in Japanese encephalitis (JE), sponsored by Sanofi. Started Nov 2013; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01981967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01981967.